US 11,706,876 B2
Pre-connected analyte sensors
Jason Halac, San Diego, CA (US); John Charles Barry, San Diego, CA (US); Chris W. Dring, Fremont, CA (US); David A. Keller, Encinitas, CA (US); Craig Thomas Gadd, Lemon Grove, CA (US); and Kyle Thomas Stewart, San Diego, CA (US)
Assigned to DexCom, Inc., San Diego, CA (US)
Filed by DexCom, Inc., San Diego, CA (US)
Filed on Apr. 12, 2022, as Appl. No. 17/719,181.
Application 17/719,181 is a continuation of application No. 17/464,547, filed on Sep. 1, 2021, granted, now 11,350,862.
Application 17/464,547 is a continuation of application No. 17/369,535, filed on Jul. 7, 2021, granted, now 11,160,926, issued on Nov. 2, 2021.
Application 17/369,535 is a continuation of application No. 16/167,976, filed on Oct. 23, 2018, granted, now 11,382,540.
Claims priority of provisional application 62/576,560, filed on Oct. 24, 2017.
Prior Publication US 2022/0233106 A1, Jul. 28, 2022
Int. Cl. A61B 5/1473 (2006.01); H05K 3/32 (2006.01); A61B 5/1486 (2006.01); A61B 5/145 (2006.01); G01N 27/327 (2006.01); G01N 33/66 (2006.01); A61B 5/1495 (2006.01); A61B 5/00 (2006.01); A61M 15/00 (2006.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); A61M 5/142 (2006.01); A61M 5/172 (2006.01); A61M 5/20 (2006.01); A61M 11/00 (2006.01); A61M 35/00 (2006.01); A61M 5/00 (2006.01); A61M 5/178 (2006.01); A61M 5/30 (2006.01)
CPC H05K 3/321 (2013.01) [A61B 5/1495 (2013.01); A61B 5/14532 (2013.01); A61B 5/14546 (2013.01); A61B 5/14865 (2013.01); A61B 5/6801 (2013.01); A61B 5/6849 (2013.01); A61M 5/14244 (2013.01); A61M 5/14276 (2013.01); A61M 5/1723 (2013.01); A61M 5/20 (2013.01); A61M 11/00 (2013.01); A61M 15/008 (2014.02); A61M 15/0065 (2013.01); A61M 15/0068 (2014.02); A61M 15/0083 (2014.02); A61M 35/00 (2013.01); G01N 27/3273 (2013.01); G01N 27/3274 (2013.01); G01N 33/66 (2013.01); G16H 20/17 (2018.01); G16H 40/63 (2018.01); A61B 5/0031 (2013.01); A61B 2560/0468 (2013.01); A61B 2562/043 (2013.01); A61B 2562/08 (2013.01); A61B 2562/085 (2013.01); A61B 2562/12 (2013.01); A61B 2562/125 (2013.01); A61B 2562/16 (2013.01); A61M 5/003 (2013.01); A61M 5/178 (2013.01); A61M 5/30 (2013.01); A61M 15/00 (2013.01); A61M 2005/14296 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/52 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/587 (2013.01); A61M 2205/8206 (2013.01); A61M 2230/201 (2013.01); Y10T 29/49169 (2015.01)] 25 Claims
OG exemplary drawing
 
1. A wearable device for measuring an analyte concentration in a host, the wearable device comprising:
a housing;
a transcutaneous analyte sensor comprising:
an in-vivo portion configured to be inserted in a living body of a host during a sensor session, wherein the in-vivo portion comprises an electrode, wherein the electrode is configured to generate a signal indicative of an analyte concentration;
an ex-vivo portion configured to remain outside the living body of the host during the sensor session;
a first printed circuit board substrate;
a second printed circuit board substrate, wherein the second printed circuit board substrate is positioned adjacent to and substantially parallel with the first printed circuit board substrate;
sensor electronics configured to process the signal generated by the electrode, wherein the sensor electronics comprises conductive components mounted to one or both of the first printed circuit board substrate and the second printed circuit board substrate; and
at least one opening in one or both of the first printed circuit board substrate and the second printed circuit board substrate, wherein the at least one opening is aligned with at least one of the conductive components mounted on the other of the first printed circuit board substrate or the second printed circuit board substrate.